Kanamycin

Paul G. Auwaerter, M.D., Kathryn Dzintars, Pharm.D., BCPS
Pediatric Dosing Author: Bethany Sharpless Chalk, Pharm.D., BCPPS

INDICATIONS

Short-term treatment of infections caused by E. coli, Proteus species (indole-positive and indole-negative), Enterobacter aerogenes, Klebsiella pneumoniae, Serratia marcescens, and Acinetobacter species.
- Note: other aminoglycosides, including gentamicin, tobramycin, and/or amikacin, are preferred in this setting.
Staphylococcal infections (not drug of choice)
Hepatic encephalopathy (oral formulation, no longer available in the U.S.)
Bowel decontamination (oral formulation, no longer available in the U.S.)

Treatment of multi-drug resistant Mycobacterium tuberculosis (previously second line)
Non-tubercular mycobacterial (NTM) infections
Gonorrhea
Urinary tract infections

There's more to see -- the rest of this topic is available only to subscribers.

All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.